European defense stocks surged on Monday, the first trading session since President Donald Trump shocked the world by scolding Ukrainian President Volodymyr Zelensky, telling the embattled leader he ...

U.S. stocks endured another serious setback on Monday as what one trader described as a tariff "tape bomb" from President Donald Trump caused the S&P 500 to tally its biggest daily drop in months.

Specifically, the likelihood that Canada’s Drug Agency would recommend that the federal government, provinces, and ...

Brands That Matter panel to examine Purdue-led pharmaceutical transformations ...

As biopharma players continue to parse out what the second Trump Administration means for the industry, Pfizer CEO Albert ...

Qomel Company’s CEO Hisham Alagla said that construction of the new pharmaceutical plant nears completion. Production is ...

Manns said Bayer “urgently” needed to reduce its net financial debt. The consensus forecast from analysts is that, despite a radical dividend cut in 2024, debt declined by only €1.2bn to €33.3bn at ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

Collegium Pharmaceutical, Inc. reported strong Q4 results last week where the company easily beat on the bottom line and grew ...

Solving the shortage problem of Ketamine and unlocking its pharmaceutical potential Toronto, Ontario-- (Newsfile Corp. - March 3, 2025) - PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE: PHRM) (the ...

Rosacea treatment is a marathon — not a sprint — and there’s a need for increased emphasis on a patient-centric approach to ...

Glenmark Pharmaceuticals Inc., USA (Glenmark) announces the acquisition and launch1 of Acetylcysteine Injection, 6 gm/30 mL ...